SpoIVA SpoVM Particle Constructs for Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current technologies face challenges in recreating the durable and complex structure of the bacterial spore coat for use in drug delivery and environmental remediation due to its recalcitrance to biochemical analysis and the need for living organisms in existing display systems.
Innovation Solution
Reconstituting components of the spore coat on a solid support coated with a lipid bilayer, incorporating SpoVM and SpoIVA, to create artificial spore-like particle constructs that can be used as versatile platforms for displaying molecules such as drugs, vaccines, and enzymes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Strength
If the bacterial spore coat structure is used for drug delivery and environmental remediation, then durability and protective function are improved, but the recalcitrance to biochemical analysis and complexity of reconstruction worsen
Solution Approach 1:
The spore coat structure is segmented into essential functional components (coat proteins, lipid bilayer, core) and reconstructed step-by-step in a controlled manner, allowing durability to be achieved while managing complexity through modular assembly
Solution Approach 2:
Instead of directly using the complex natural spore coat, a simplified copy or model is created using purified recombinant proteins and synthetic lipids, capturing the essential protective functions while eliminating the complexity of the complete natural structure
2Adaptability or versatility
If living organisms are used in existing display systems, then biological functionality is improved, but the need for living organisms increases system complexity and reduces control
Solution Approach 1:
The essential functional elements (coat proteins SpoIVA and SpoVM) are extracted from living organisms and reconstituted in a controlled in vitro system, maintaining biological functionality while eliminating the need for living organisms and associated complexity
Solution Approach 2:
The reconstituted particle constructs autonomously display molecules of interest without requiring living organisms, achieving biological functionality through self-organized assembly of purified components
3Reliability
If the complete spore coat is reconstructed, then protective function is improved, but the difficulty of biochemical analysis worsens
Solution Approach 1:
The protective function is extracted and reproduced using only the essential coat protein components (SpoIVA and SpoVM) rather than the complete spore coat, maintaining reliability while enabling biochemical analysis of the simplified system
Solution Approach 2:
The reconstruction focuses on the specific local functional elements (basement layer proteins) that provide protective function, rather than reproducing the entire complex spore coat structure, making biochemical analysis feasible
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The particle constructs provide a defined composition for precise molecule display, avoiding extraneous proteins and enabling fine-tuned immune responses, and can be used for treating infections, delivering vaccines, and degrading environmental pollutants.
Implementation Method 1
SpoVM, a 26 amino acid amphipathic α-helical protein that preferentially embeds onto positively curved membranes
Implementation Method 2
The N-terminus of SpoIVA binds and hydrolyzes adenosine tri-phosphate (ATP) via a predicted structural fold that resembles the TRAFAC class of P-loop GTPases
Implementation Method 3
ATP hydrolysis drives a structural change in SpoIVA that is required for its irreversible polymerization into a static polymer
Implementation Method 4
a solid support coated with a lipid bilayer
Data Source
AI summary
A particle construct is disclosed that includes a synthetic core with a solid surface coated with a lipid bilayer, SpoVM adhered to the lipid bilayer; and SpoIVA adsorbed to the SpoVM. In additional embodiments, an agent of interest can be covalently linked to the SpoIVA. In specific, non-limiting examples, the agent of interest is an enzyme, a detectable marker, a pharmaceutical compound, an immunosuppressant or a vaccine. Methods of using the particle constructs are disclosed, such as for treating infections, treating a tumor, delivering a vaccine, treating an autoimmune disorder or ameliorating an allergic reaction. Method are also disclosed for degrading an environmental pollutant. Methods are also disclosed for producing these particle constructs.